4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-24-000008
Director sold 8,391 shares at $22.99 ($192,909)
- Director acquired 17,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
FOUSE JACQUALYN A · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-01-05 | Exercise or conversion : show line 1 in the form 10b5-1 | +17,500 | 124,466 | D | ||
| 2024-01-09 | Sale : show line 2 in the form 10b5-1 | −8,391 | $22.99 | $192,909 | 116,075 | D |
| Open-market sales · 8,391 sh · avg $22.99 · $192,909 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-01-05 | Exercise or conversion : show line 3 in the form 10b5-1 Performance share units | −17,500 | 0 | D |
Loading xslF345X05/wk-form4_1704835604.xml…